Nanoparticles attack head/neck cancer
Using tumor-targeted nanoparticles to deliver high doses of anticancer agents directly to head and neck tumors increases survival while triggering fewer side effects, according to a study in the Journal of Oral and Maxillofacial Surgery (June 20, 2011). Researchers at the University of Michigan created a spherical polymeric nanoparticle known as a dendrimer to deliver the drug methotrexate to head and neck tumors in mice. To target the nanoparticle to

